Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Valentina Bonuomo
Observed names:
BONUOMO, VALENTINA,
Bonuomo V,
Bonuomo Valentina,
Bonuomo, Valentina,
V Bonuomo,
V. Bonuomo
show all 6
Institutions:
University of Verona,
A. O. Ordine Mauriziano di Torino,
University of Turin
Observed institutions:
University of Verona,
Azienda Ospedaliera Universitaria Integrata Verona,
Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari,
A. O. Ordine Mauriziano di Torino,
University of Turin
ORCID:
0000-0001-6491-8337
Observed ORCID:
0000-0001-6491-8337
OpenAlex ID:
A5075689748
COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)
2021
·
Livio Pagano
, Jon Salmanton-García
, et al.
·
Journal of Hematology & Oncology
·
316
PDF
Do high MICs predict the outcome in invasive fusariosis?
2020
·
Marcio Nucci
, Jeffrey Jenks
, et al.
·
Journal of Antimicrobial Chemotherapy
·
59
PDF
A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study
2021
·
Carlo Visco
, Luigi Marcheselli
, et al.
·
Blood Advances
·
55
PDF
COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA)
2022
·
Francesco Marchesi
, Jon Salmanton-García
, et al.
·
Haematologica
·
50
PDF
Bloodstream infections due to Gram-negative bacteria in patients with hematologic malignancies: updated epidemiology and risk factors for multidrug-resistant strains in an Italian perspective survey
2023
·
Enrico Maria Trecarichi
, Gabriele Giuliano
, et al.
·
International Journal of Antimicrobial Agents
·
38
Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022
2024
·
Jon Salmanton-García
, Francesco Marchesi
, et al.
·
EClinicalMedicine
·
35
PDF
COVID-19 (SARS-CoV-2 infection) in lymphoma patients: A review
2021
·
Valentina Bonuomo
, Isacco Ferrarini
, et al.
·
World Journal of Virology
·
35
SF3B1 Mutations in Hematological Malignancies
2022
·
Daniela Cilloni
, Federico Itri
, et al.
·
Cancers
·
25
PDF
Efficacy of R-COMP in comparison to R-CHOP in patients with DLBCL: A systematic review and single-arm metanalysis
2021
·
Carlo Visco
, Francesca Pregnolato
, et al.
·
Critical Reviews in Oncology/Hematology
·
25
PDF
Prospective multicenter study on infectious complications and clinical outcome of 230 unfit acute myeloid leukemia patients receiving first‐line therapy with hypomethylating agents alone or in combination with Venetoclax
2023
·
Anna Candoni
, Davide Lazzarotto
, et al.
·
American Journal of Hematology
·
24
PDF
Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings
2023
·
Giuseppe Rossi
, Jon Salmanton-García
, et al.
·
International Journal of Infectious Diseases
·
19
PDF
B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA)
2022
·
Maria Stefania Infante
, Jon Salmanton-García
, et al.
·
Frontiers in Oncology
·
19
PDF
Survival in multiple myeloma and SARS‐COV‐2 infection through the COVID‐19 pandemic: Results from the EPICOVIDEHA registry
2023
·
Pellegrino Musto
, Jon Salmanton‐García
, et al.
·
Hematological Oncology
·
16
PDF
High Incidence of Invasive Fungal Diseases in Patients with FLT3-Mutated AML Treated with Midostaurin: Results of a Multicenter Observational SEIFEM Study
2022
·
Chiara Cattaneo
, Francesco Marchesi
, et al.
·
Journal of Fungi
·
16
PDF
Detection of KIT Mutations in Systemic Mastocytosis: How, When, and Why
2024
·
Daniela Cilloni
, Beatrice Maffeo
, et al.
·
International Journal of Molecular Sciences
·
14
Multicenter Observational Retrospective Study on Febrile Events in Patients with Acute Myeloid Leukemia Treated with Cpx-351 in “Real-Life”: The SEIFEM Experience
2023
·
Luana Fianchi
, Fabio Guolo
, et al.
·
Cancers
·
11
PDF
Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey
2024
·
Tobias Lahmer
, Jon Salmanton-García
, et al.
·
Infection
·
10
The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey
2023
·
Shaimaa El-Ashwah
, Jon Salmanton-García
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
10
PDF
Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registry
2023
·
Monia Marchetti
, Jon Salmanton-García
, et al.
·
Therapeutic Advances in Hematology
·
9
SARS-CoV-2 Infection In Patients With Mastocytosis: An EPICOVIDEHA Report
2022
·
M Criscuolo
, J Salmanton-García
, et al.
·
Journal of Investigational Allergology and Clinical Immunology
·
5
PDF
Ultra-Sensitive Mutation Detection Technology in Myeloid Neoplasms: New Tools for Patient Monitoring
2026
·
Alessandro Ferrando
, Valentina Bonuomo
, et al.
·
Journal of Clinical Medicine
·
4
PDF
Risk of Cardiovascular and Cerebrovascular Diseases in Patients with Myeloid Neoplasms: Results from 1.8 Million Inhabitants of Northwest Italy
2025
·
Alberto Catalano
, Valentina Bonuomo
, et al.
·
Cancer Epidemiology Biomarkers & Prevention
·
4
Ibrutinib-Associated Liver Injury in a Patient with Chronic Lymphocytic Leukemia: Clinical Course and Therapeutic Approach
2025
·
Antonio Frolli
, Guido Parvis
, et al.
·
Hematology Reports
·
2
PDF
The Dual Role of Interferon Signaling in Myeloproliferative Neoplasms: Pathogenesis and Targeted Therapeutics
2025
·
Valentina Bonuomo
, Irene Dogliotti
, et al.
·
Cancers
·
2
PDF
CML-180 Role of Gut Microbiota in Defining the Clinical Outcomes of Patients With Chronic Myeloid Leukemia
2024
·
Carmen Fava
, Selene Grano
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
2
Show more works
View as search
Works count:
68
Citation count:
812
H-index:
14
I10-index:
18
Year
Topic
Type